Funding news
Riboscience logo

Riboscience Raises $146.8

Recently funded · $146.8M Series aHospitals and Health CareUSView source

Get the full Riboscience company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Clinical stage biotechnology firm Riboscience has landed a substantial $146.8M in Series A funding, signaling continued investor confidence in the fight against serious infectious diseases and cancer. The capital infusion marks a significant milestone for the company as it advances its drug discovery pipeline.

Riboscience specializes in applying ribose and structure-guided design technologies. Its approach targets proteins essential and unique to specific infectious pathogens, tumor cells, or the anti-tumor immune response, aiming to develop novel treatments for these challenging conditions.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Passage Ticketing logo

Passage Ticketing

United States

$610.0K
2
InvestorHub logo

InvestorHub

Australia

$3.0M
3
Mister IA logo

Mister IA

France

$10.0M
4
OneReg logo

OneReg

New Zealand

$4.4M
5
YesMadam logo

YesMadam

India

$6.0M